Figure 1From: Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis Urinary suPAR levels among patients with primary FSGS, minimal change disease, membranous nephropathy, secondary FSGS and normal subjects. FSGS, focal segmental glomerulosclerosis; suPAR, soluble urokinase receptor.Back to article page